Tom Brady, Ph.D.

Senior Principle Scientist
Cidara Therapeutics

Disclosure: Cidara Therapeutics (Individual(s) Involved: Self): Shareholder

Presentation(s):

• 159 - efficacy of CD377, a Novel Antiviral Fc-conjugate, Against Seasonal Influenza in Lethal Mouse Infection Models

  Oral Abstract